Doha Bank Q.P.S.C. (QSE:DHBK)
Qatar · Delayed Price · Currency is QAR 2.550
+0.031 (1.23%)
Aug 13, 2025, 1:12 PM AST
ASLAN Pharmaceuticals Income Statement
Financials in millions QAR. Fiscal year is January - December.
Millions QAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 6,324 | 6,357 | 5,602 | 3,945 | 3,558 | 3,744 | Upgrade |
Interest Paid on Deposits | 4,318 | 4,366 | 3,486 | 1,623 | 972.39 | 1,424 | Upgrade |
Net Interest Income | 2,006 | 1,992 | 2,116 | 2,322 | 2,585 | 2,320 | Upgrade |
Net Interest Income Growth (YoY) | -3.08% | -5.87% | -8.89% | -10.17% | 11.44% | 17.15% | Upgrade |
Gain (Loss) on Sale of Assets | 0.19 | 0.19 | -1.45 | 0 | 0.01 | -0.17 | Upgrade |
Gain (Loss) on Sale of Investments | 18.16 | -48.3 | 122.6 | -244.92 | -57.75 | 159.09 | Upgrade |
Other Non-Interest Income | 643.09 | 626.09 | 611.15 | 599.7 | 513.51 | 461.85 | Upgrade |
Total Non-Interest Income | 661.45 | 577.99 | 732.3 | 354.78 | 455.77 | 620.77 | Upgrade |
Non-Interest Income Growth (YoY) | -8.75% | -21.07% | 106.41% | -22.16% | -26.58% | -22.12% | Upgrade |
Revenues Before Loan Losses | 2,668 | 2,570 | 2,848 | 2,677 | 3,041 | 2,941 | Upgrade |
Provision for Loan Losses | 722.7 | 702.03 | 892.36 | 969.67 | 1,419 | 1,369 | Upgrade |
Revenue | 1,945 | 1,868 | 1,956 | 1,707 | 1,621 | 1,572 | Upgrade |
Revenue Growth (YoY) | -1.18% | -4.51% | 14.55% | 5.30% | 3.16% | -5.29% | Upgrade |
Salaries and Employee Benefits | 583.38 | 560.62 | 521.15 | 501.08 | 466.91 | 441.23 | Upgrade |
Occupancy Expenses | 73.86 | 80.3 | 89.38 | 99.9 | 105.1 | 117.29 | Upgrade |
Selling, General & Administrative | 20.21 | 20.21 | 12.87 | 15.42 | 7.31 | 19 | Upgrade |
Other Non-Interest Expense | 370.38 | 349.01 | 306.79 | 277.63 | 296.6 | 289.95 | Upgrade |
Total Non-Interest Expense | 1,047 | 1,009 | 929.63 | 893.79 | 875.15 | 867.52 | Upgrade |
EBT Excluding Unusual Items | 897.74 | 858.27 | 1,026 | 813.68 | 746.32 | 704.29 | Upgrade |
Legal Settlements | - | - | -161.65 | - | - | - | Upgrade |
Pretax Income | 897.74 | 858.27 | 864.66 | 813.68 | 746.32 | 704.29 | Upgrade |
Income Tax Expense | 11.27 | 6.81 | 95.19 | 48.31 | 42.55 | 1.27 | Upgrade |
Net Income | 886.47 | 851.46 | 769.48 | 765.38 | 703.77 | 703.02 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 203 | Upgrade |
Net Income to Common | 886.47 | 851.46 | 769.48 | 765.38 | 703.77 | 500.02 | Upgrade |
Net Income Growth | 9.47% | 10.65% | 0.54% | 8.75% | 0.11% | -6.75% | Upgrade |
Basic Shares Outstanding | 3,100 | 3,100 | 3,100 | 3,100 | 3,100 | 3,100 | Upgrade |
Diluted Shares Outstanding | 3,100 | 3,100 | 3,100 | 3,100 | 3,100 | 3,100 | Upgrade |
EPS (Basic) | 0.29 | 0.27 | 0.25 | 0.25 | 0.23 | 0.16 | Upgrade |
EPS (Diluted) | 0.29 | 0.27 | 0.25 | 0.25 | 0.23 | 0.16 | Upgrade |
EPS Growth | 9.47% | 10.65% | 0.54% | 8.75% | 40.75% | -6.35% | Upgrade |
Dividend Per Share | 0.100 | 0.100 | 0.075 | 0.075 | 0.075 | 0.075 | Upgrade |
Dividend Growth | 33.33% | 33.33% | - | - | - | - | Upgrade |
Effective Tax Rate | 1.26% | 0.79% | 11.01% | 5.94% | 5.70% | 0.18% | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.